Cost-Effectiveness Analysis of First-Line Treatment With Biologic Agents in Polyarticular Juvenile Idiopathic Arthritis.

about

Cost-Effectiveness Analysis of First-Line Treatment With Biologic Agents in Polyarticular Juvenile Idiopathic Arthritis.

Item

http://www.wikidata.org/entity/Q51759532

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Cost-Effectiveness Analysis of ...... Juvenile Idiopathic Arthritis.

@en

Cost-Effectiveness Analysis of ...... Juvenile Idiopathic Arthritis.

@nl

type

Item

label

Cost-Effectiveness Analysis of ...... Juvenile Idiopathic Arthritis.

@en

Cost-Effectiveness Analysis of ...... Juvenile Idiopathic Arthritis.

@nl

prefLabel

Cost-Effectiveness Analysis of ...... Juvenile Idiopathic Arthritis.

@en

Cost-Effectiveness Analysis of ...... Juvenile Idiopathic Arthritis.

@nl

P1476

Cost-Effectiveness Analysis of ...... Juvenile Idiopathic Arthritis.

@en

P2093

Ahmed M Bayoumi

http://www.w3.org/2001/XMLSchema#string

Brian M Feldman

http://www.w3.org/2001/XMLSchema#string

Gwen Schwartz

http://www.w3.org/2001/XMLSchema#string

Heather F Burnett

http://www.w3.org/2001/XMLSchema#string

Myla E Moretti

http://www.w3.org/2001/XMLSchema#string

Nadia J Luca

http://www.w3.org/2001/XMLSchema#string

Timothy Beukelman

http://www.w3.org/2001/XMLSchema#string

Wendy J Ungar

http://www.w3.org/2001/XMLSchema#string

P2860

Adult outcomes of childhood-onset rheumatic diseases

Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry.

Long-term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid arthritis.

Adalimumab with or without methotrexate in juvenile rheumatoid arthritis.

Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial.

Biosimilars: the debate continues.

The German etanercept registry for treatment of juvenile idiopathic arthritis.

2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features.

Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis.

What are the costs of childhood-onset rheumatic disease?

P304

1803-1811

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ACR.22903

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27059807

http://www.w3.org/2001/XMLSchema#string

P921

juvenile rheumatoid arthritis